FDA's review process under investigation

RSS

AP/Yahoo News, March 5, 2008

The Government Accountability Office is investigating whether the Food and Drug Administration's drug-review process cleared two blockbuster medications without sufficient proof of their safety or effectiveness. Sen. Charles Grassley suggested the investigation after recent studies showed the drugs may not lower the risk of heart attack and artery-clogging plaque, as assumed by millions of patients and doctors.

Full Story

A bid to expand eligibility for weight-loss surgery

A Food and Drug Administration advisory panel last month recommended allowing doctors to use the Lap-Band, a less drastic form of weight-loss surgery, in somewhat thinner, but still obese patients. Those...

J&J recalls hip replacement implant

More than two years after the Food and Drug Administration began receiving complaints about the failure of a hip replacement implant made by the DePuy Orthopaedics unit of Johnson & Johnson, the...

Medical device makers pan FDA proposals

Proposed changes to the U.S. system for regulating medical devices are more objectionable to the industry than some local experts expected. Late Tuesday, the Food and Drug Administration issued a...

Webcast: OPPE Best Practices Series: When OPPE leads to FPPE

Join speakers Valerie Handunge, MA, senior healthcare strategy and operations consultant, Deloitte Consulting, and Evalynn Buczkowski, RN, BSN, MS, regional director, clinical performance...

go to complete list